Cu(7)S(4) Nanozyme Efficiently Inactivating Drug-Resistant Bacteria on Mouse Wound Models through Photodynamic and Photothermal Synergetic Therapy

Cu(7)S(4)纳米酶通过光动力和光热协同疗法高效灭活小鼠伤口模型上的耐药菌

阅读:2

Abstract

The rapid emergence of drug-resistant bacteria has outpaced the development of traditional antibiotics, necessitating the exploration of more effective therapeutic strategies. In this study, the design of a Cu(7)S(4) multifunctional nanozyme, activated by near-infrared (NIR) light is presented, that demonstrates enhanced antibacterial activity. Cu(7)S(4) is synthesized with varying defect structures by utilizing different templates, which substantially optimize its absorption to H(2)O(2) and lipopolysaccharides (LPS) molecules. This process generates an optimal electronic structure, producing efficient antibacterial activity through photodynamic and photothermal synergetic processes. Specifically, the Cu(7)S(4) nanozyme with dual defects (VCu and VCuCuCuSSS) exhibits peroxidase-like (POD), catalase-like (CAT), and GSH-depletion properties, effectively inactivating drug-resistant bacteria such as Pseudomonas aeruginosa. Notably, in a mouse wound model infected with P. aeruginosa, the nanozyme demonstrates significant antibacterial efficacy, promoting wound healing under NIR light. This multifunctional Cu(7)S(4) nanozyme presents a promising new strategy for combating drug-resistant bacterial infections.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。